Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-02

Clinical Trial Update: The ImPact of Trimetazidine on MicrOcirculation After Stenting for Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial updating on the effects of trimetazidine on microcirculation after stenting in stable coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trimetazidine (trimetazidine)

Snippet

Sponsor: Clinical Hospital Center Zemun | Conditions: Coronary Artery Disease, Microcirculation | Phase 4 | Status: COMPLETED